Aghoghovwia(BE),Ban(K),Stavropoulos(D),Che... Neuro Oncol 2026-07-21

...CSF1R inhibitor) to reduce monocytes numbers or using clemastine to promote the generation and survival of oligodendrocy...

Zhao(ZY),Yuan(WQ),Zhao(D),Zhang(MY),Han(XY... BMC Vet Res 2026-01-06

...CSF1R-ERK1/2-RSK2 signaling axis and enhancing the acetylation levels at histone H3K9 and H3K27 sites. This finding prov...

Xie(S),Yang(Q),Pan(M),Hu(Y),Huang(N),Chen(... Neurogenetics 2026-05-18

...CSF1R variants, which lead to microglial dysfunction and progressive white matter degeneration. This study identified CS...

Lin(HJ),Liu(Y),Langevin(B),Lin(J) Cancers (Basel) 2026-05-14

...CSF1R, STAT3, IL-6, YAP, PI3K, PDK1, and AKT. These modulators could be released from or activated by surrounding malign...

Xiao(B),Chen(YQ),Wang(S) Biomedicines 2026-04-27

...CSF1R are primary exploratory candidates given structurally validated binding pockets. Triplicate MD simulations (15 μs ...

Carreras(J) Biomedicines 2026-05-17

...CSF1R, CASP8, TNFAIP8, LMO2, MYC, MDM2, CDK6, and TP53 markers at a quantitative level. Conclusions: The DLBCL overall s...

Lemire(CA),Rajesh(A),Viniak(R),Lavine(JA) Invest Ophthalmol Vis Sci 2026-05-01

...CSF1R) antagonist, respectively. Retinal venules contained discrete LERs characterized by reduced expression of both col...

Nagra(A),Chen(LY),Saeidiborojeni(S),Rosin(... J Dev Biol 2026-05-18

...CSF1R during tooth development and inhibited CSF1R pharmacologically in utero using PLX5622 during early stages of tooth...

Lyu(G),Li(D) CNS Neurol Disord Drug Targets 2026-03-11

...CSF1R modulators are entering phase II trials, while TSPO-PET and plasma GFAP provide pharmacodynamic read-outs. Epigene...

Zhu(Z),Zhang(M),Song(Y),Jiang(W),Cao(F),Ya... Genomics Proteomics Bioinfo... 2026-03-15

...CSF1R) receptor-ligand axis, establishing a feedforward signaling loop that sustains lineage plasticity. Functional vali...